Amanda E. Allen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and incidence rates are rising. Both detection and treatment options for pancreatic cancer are limited, providing a less than 5% five-year survival advantage. The need for new biomarkers for early detection and treatment of pancreatic cancer demands the efficient(More)
  • 1